28th February 2022 | Pharma Updates
Sun Pharma Gets CDSCO Nod to Conduct Phase IV Clinical Study of Cyclosporine Ophthalmic Solution
The solution is used to increase tear production in patients with moderate to severe keratoconjunctivitis sicca.
SII seeks DCGI's approval for phase-III trial of Covovax as booster shot
The vaccine is yet to be added to the vaccination programme.
Reata Pharma Gets CRL From The USFDA for Bardoxolone
US’s drug regulator has issued a Complete Response Letter regarding the New Drug Application for bardoxolone methyl.
FDA to Review Pfizer Biosimilar for Humira
An interchangeability designation for ABRILADA would lead to cost savings, said Mike Gladstone, Global President, Inflammation and Immunology, Pfizer.
GC Pharma Gets CRL for ALYGLO
The US FDA issues a complete response letter to indicate that the review cycle for Biologics License Application is complete but the application cannot be approved in its current structure.
Health Canada Okays Plant-based Covid Vaccine for adults
Medicago’s Covid vaccine became the first plant-based vaccine against Covid infections.
HMC begins nuclear treatment of tumours
Hamad Medical Corporation starts Nuclear Treatment of tumours after the opening of the first Radiopharmaceutical Lab in Qatar.
Malawi RestocksAstraZeneca Covid Vaccine
Malawi Health Minister, Khumbize Kandodo-Chiponda, said that Malawi feels honoured to receive the Covid vaccine donation when it is needed most.
23.8% of Malaysian kids given first vaccine dose
Around 62% of Malaysia’s adult population had received a booster shot; 97.5% had completed their vaccination; 98.7% had received at least one Covid vaccine dose.
Nepal inks non-disclosure agreement to purchase 8.4 mn Pfizer doses for kids
Nepal’s government also signed a deal for a USD 18 mn loan with the World Bank Friday for buying the Covid vaccine.
